Brief: Autonomix Medical Announces Abstract Acceptances At Europcr 2026 Showcasing Long-Term Data In Pancreatic Cancer Pain Mitigation
18/05/2026 14:27
May 18 (Reuters) - Autonomix Medical Inc AMIX.O: AUTONOMIX MEDICAL ANNOUNCES ABSTRACT ACCEPTANCES AT EUROPCR 2026 SHOWCASING LONG-TERM DATA IN PANCREATIC CANCER PAIN MITIGATION Source text: ID:nGNX7xs6Nd Further company coverage: AMIX.O ((Reuters.Briefs@thomsonreuters.com;))